Infinity Biologix: Amit Bhalla

Infinity Biologix  has appointed Amit Bhalla as its vice president and CFO. He will lead the company's financial operations as it enters its next phase of growth after spinning out from Rutgers University in August. IBX is a central lab that provides sample collection and processing, storage, analytical services, and scientific and technical support. It received Emergency Use Authorization from the US Food and Drug Administration for its saliva-based test for detecting SARS-CoV-2 in April.

Balla joins the firm after more than 20 years of experience on Wall Street and in the healthcare industry. He was most recently senior healthcare analyst at Lord, Abbett and previously had senior roles at Becton Dickinson, Citigroup, Morgan Stanley, and Johnson & Johnson.